{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T03:39:50Z","timestamp":1767929990513,"version":"3.49.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,8]]},"DOI":"10.7759\/cureus.101110","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T22:12:47Z","timestamp":1767910367000},"source":"Crossref","is-referenced-by-count":0,"title":["Prolonged Cholestatic Hepatitis A in an Unvaccinated International Traveler"],"prefix":"10.7759","author":[{"given":"Erika Yuki M","family":"Bomfim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o Vitor M","family":"Viana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella Cec\u00edlia","family":"Vanin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana S","family":"Kajita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcos  V","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-021-10232-4","article-title":"The global trends and regional differences in incidence and mortality of hepatitis A from 1990 to 2019 and implications for its prevention","volume":"15","author":"Cao G","year":"2021","unstructured":"Cao G, Jing W, Liu J, Liu M. The global trends and regional differences in incidence and mortality of hepatitis A from 1990 to 2019 and implications for its prevention. Hepatol Int. 2021, 15:1068-82. 10.1007\/s12072-021-10232-4","journal-title":"Hepatol Int"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001921","article-title":"World Health Organization estimates of the global and regional disease burden of 22 foodborne bacterial, protozoal, and viral diseases, 2010: a data synthesis","volume":"12","author":"Kirk MD","year":"2015","unstructured":"Kirk MD, Pires SM, Black RE, et al.. World Health Organization estimates of the global and regional disease burden of 22 foodborne bacterial, protozoal, and viral diseases, 2010: a data synthesis. PLoS Med. 2015, 12:e1001921. 10.1371\/journal.pmed.1001921","journal-title":"PLoS Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/s0264-410x(99)00470-3","article-title":"Clinical course and consequences of hepatitis A infection","volume":"18","author":"Ciocca M","year":"2000","unstructured":"Ciocca M. Clinical course and consequences of hepatitis A infection. Vaccine. 2000, 18:S71-4. 10.1016\/s0264-410x(99)00470-3","journal-title":"Vaccine"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a031708","article-title":"Natural history, clinical manifestations, and pathogenesis of hepatitis A","volume":"8","author":"Shin EC","year":"2018","unstructured":"Shin EC, Jeong SH. Natural history, clinical manifestations, and pathogenesis of hepatitis A. Cold Spring Harb Perspect Med. 2018, 8:10.1101\/cshperspect.a031708","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref5","article-title":"Hepatitis A","author":"Foster MA","year":"2024","unstructured":"Foster MA, Haber P, Nelson NP. Hepatitis A. CDC Pink Book. Centers for Disease Control and Prevention, Atlanta, GA; 2024."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410x(92)90534-q","article-title":"Atypical clinical manifestations of hepatitis A","volume":"10 Suppl 1","author":"Schiff ER","year":"1992","unstructured":"Schiff ER. Atypical clinical manifestations of hepatitis A. Vaccine. 1992, 10 Suppl 1:S18-20. 10.1016\/0264-410x(92)90534-q","journal-title":"Vaccine"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3109\/00365548.2013.805425","article-title":"Genotypic shift of the hepatitis A virus and its clinical impact on acute hepatitis A in Korea: a nationwide multicenter study","volume":"45","author":"Kim JH","year":"2013","unstructured":"Kim JH, Yeon JE, Baik SK, et al.. Genotypic shift of the hepatitis A virus and its clinical impact on acute hepatitis A in Korea: a nationwide multicenter study. Scand J Infect Dis. 2013, 45:811-8. 10.3109\/00365548.2013.805425","journal-title":"Scand J Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a031716","article-title":"Globalization and the changing epidemiology of hepatitis A virus","volume":"8","author":"Jacobsen KH","year":"2018","unstructured":"Jacobsen KH. Globalization and the changing epidemiology of hepatitis A virus. Cold Spring Harb Perspect Med. 2018, 8:10.1101\/cshperspect.a031716","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1590\/s0102-311x2012000200002","article-title":"Contributions from the systematic review of economic evaluations: the case of childhood hepatitis A vaccination in Brazil","volume":"28","author":"De So\u00e1rez PC","year":"2012","unstructured":"De So\u00e1rez PC, Sartori AM, Santos A, Itria A, Novaes HM, Martelli CM. Contributions from the systematic review of economic evaluations: the case of childhood hepatitis A vaccination in Brazil. Cad Saude Publica. 2012, 28:211-28. 10.1590\/s0102-311x2012000200002","journal-title":"Cad Saude Publica"},{"key":"ref10","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Secretaria de Vigil\u00e2ncia em Sa\u00fade. Informe t\u00e9cnico da introdu\u00e7\u00e3o da vacina adsorvida hepatite A (inativada). Minist\u00e9rio da Sa\u00fade, Bras\u00edlia, Brazil. (2013). Accessed: June 17, 2025: https:\/\/www.saude.df.gov.br\/documents\/37101\/87308\/Informe_t%C3%A9cnico_vacina_hepatite_A.pdf\/c0fe3762-32b6-2e79-9244-...."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0094622","article-title":"Modelling the force of infection for hepatitis A in an urban population-based survey: a comparison of transmission patterns in Brazilian macro-regions","volume":"9","author":"Ximenes RA","year":"2014","unstructured":"Ximenes RA, Martelli CM, Amaku M, et al.. Modelling the force of infection for hepatitis A in an urban population-based survey: a comparison of transmission patterns in Brazilian macro-regions. PLoS One. 2014, 9:e94622. 10.1371\/journal.pone.0094622","journal-title":"PLoS One"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2017.1323158","article-title":"Modeling the hepatitis A epidemiological transition in Brazil and Mexico","volume":"13","author":"Van Effelterre T","year":"2017","unstructured":"Van Effelterre T, Guignard A, Marano C, Rojas R, Jacobsen KH. Modeling the hepatitis A epidemiological transition in Brazil and Mexico. Hum Vaccin Immunother. 2017, 13:1942-51. 10.1080\/21645515.2017.1323158","journal-title":"Hum Vaccin Immunother"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/taac013","article-title":"Acute hepatitis A in international travellers: a GeoSentinel analysis, 2008-2020","volume":"29","author":"Balogun O","year":"2022","unstructured":"Balogun O, Brown A, Angelo KM, et al.. Acute hepatitis A in international travellers: a GeoSentinel analysis, 2008-2020. J Travel Med. 2022, 29:10.1093\/jtm\/taac013","journal-title":"J Travel Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.21822","article-title":"Atypical manifestations of hepatitis A infection: a prospective, multicenter study in Korea","volume":"82","author":"Jung YM","year":"2010","unstructured":"Jung YM, Park SJ, Kim JS, et al.. Atypical manifestations of hepatitis A infection: a prospective, multicenter study in Korea. J Med Virol. 2010, 82:1318-26. 10.1002\/jmv.21822","journal-title":"J Med Virol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/v13101900","article-title":"Hepatitis A: epidemiology, high-risk groups, prevention and research on antiviral treatment","volume":"13","author":"Migueres M","year":"2021","unstructured":"Migueres M, Lhomme S, Izopet J. Hepatitis A: epidemiology, high-risk groups, prevention and research on antiviral treatment. Viruses. 2021, 13:10.3390\/v13101900","journal-title":"Viruses"},{"key":"ref16","article-title":"Departamento de Imuniza\u00e7\u00f5es e Doen\u00e7as Imunopreven\u00edveis. Manual dos Centros de Refer\u00eancia para Imunobiol\u00f3gicos Especiais. 6","author":"Brasil. Minist\u00e9rio da Sa\u00fade. Secretaria de Vigil\u00e2ncia em Sa\u00fade e Ambiente. Departamento de Imuniza\u00e7\u00f5es e Doen\u00e7as Imunopreven\u00edveis","year":"2023","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Secretaria de Vigil\u00e2ncia em Sa\u00fade e Ambiente. Departamento de Imuniza\u00e7\u00f5es e Doen\u00e7as Imunopreven\u00edveis. Manual dos Centros de Refer\u00eancia para Imunobiol\u00f3gicos Especiais, 6th Edition. Minist\u00e9rio da Sa\u00fade, Bras\u00edlia, Brazil; 2023. https:\/\/www.gov.br\/saude\/pt-br\/centrais-de-conteudo\/publicacoes\/guias-e-manuais\/2024\/manual-dos-centros-de-referencia...."},{"key":"ref17","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Secretaria de Vigil\u00e2ncia em Sa\u00fade e Ambiente. Programa Nacional de Imuniza\u00e7\u00f5es. (2025). Accessed. November 28, 2025: https:\/\/www.gov.br\/saude\/pt-br\/composicao\/svsa\/pni."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/cld.1134","article-title":"Tropical liver diseases: an overview","volume":"18","author":"Prahraj D","year":"2021","unstructured":"Prahraj D, Anand AC. Tropical liver diseases: an overview. Clin Liver Dis (Hoboken). 2021, 18:138-42. 10.1002\/cld.1134","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2009.02.002","article-title":"A randomized controlled trial to assess the safety and efficacy of silymarin on symptoms, signs and biomarkers of acute hepatitis","volume":"16","author":"El-Kamary SS","year":"2009","unstructured":"El-Kamary SS, Shardell MD, Abdel-Hamid M, et al.. A randomized controlled trial to assess the safety and efficacy of silymarin on symptoms, signs and biomarkers of acute hepatitis. Phytomedicine. 2009, 16:391-400. 10.1016\/j.phymed.2009.02.002","journal-title":"Phytomedicine"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/451378-prolonged-cholestatic-hepatitis-a-in-an-unvaccinated-international-traveler","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T22:12:48Z","timestamp":1767910368000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/451378-prolonged-cholestatic-hepatitis-a-in-an-unvaccinated-international-traveler"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.101110","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,8]]}}}